Vol.:(0123456789) 1 3
Human Genetics
https://doi.org/10.1007/s00439-019-02077-7
ORIGINAL INVESTIGATION
Compound heterozygous mutations in SNAP29 is associated
with Pelizaeus‑Merzbacher‑like disorder (PMLD)
Lorida Llaci
1,2
· Keri Ramsey
1,2
· Newell Belnap
1,2
· Ana M. Claasen
1,2
· Chris D. Balak
1,2
· Szabolcs Szelinger
1,2
·
Wayne M. Jepsen
1,2
· Ashley L. Siniard
1,2
· Ryan Richholt
1,2
· Tyler Izat
1
· Marcus Naymik
1,2
· Matt De Both
1,2
·
Ignazio S. Piras
1,2
· David W. Craig
1,2,3
· Matthew J. Huentelman
1,2
· Vinodh Narayanan
1,2
· Isabelle Schrauwen
1,2,4
·
Sampathkumar Rangasamy
1,2
Received: 28 July 2019 / Accepted: 22 October 2019
© Springer-Verlag GmbH Germany, part of Springer Nature 2019
Abstract
Pelizaeus-Merzbacher-like disease (PMLD) is an autosomal recessive hypomyelinating leukodystrophy, which is clini-
cally and radiologically similar to X-linked Pelizaeus-Merzbacher disease (PMD). PMLD is characterized by early-onset
nystagmus, delayed development (motor delay, speech delay and dysarthria), dystonia, hypotonia typically evolving into
spasticity, ataxia, seizures, optic atrophy, and diffuse leukodystrophy on magnetic resonance imaging (MRI). We identified
a 12-year-old Caucasian/Hispanic male with the classical clinical characteristics of PMLD with lack of myelination of the
subcortical white matter, and absence of the splenium of corpus callosum. Exome sequencing in the trio revealed novel
compound heterozygous pathogenic mutations in SNAP29 (p.Leu119AlafsX15, c.354DupG and p.0?, c.2T > C). Quantitative
analysis of the patient’s blood cells through RNA sequencing identified a significant decrease in SNAP29 mRNA expression,
while western blot analysis on fibroblast cells revealed a lack of protein expression compared to parental and control cells.
Mutations in SNAP29 have previously been associated with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
(CEDNIK) syndrome. Typical skin features described in CEDNIK syndrome, such as generalized ichthyosis and kerato-
derma, were absent in our patient. Moreover, the early onset nystagmus and leukodystrophy were consistent with a PMLD
diagnosis. These findings suggest that loss of SNAP29 function, which was previously associated with CEDNIK syndrome,
is also associated with PMLD. Overall, our study expands the genetic spectrum of PMLD.
Introduction
Pelizaeus-Merzbacher disease (PMD; MIM #312080) is a
rare, X-linked recessive hypomyelinating leukodystrophy
with prevalence among males of 1:200,000–1:500,000. PMD
is a prototypic hypomyelinating leukodystrophy (HLD) with
classic clinical features including congenital nystagmus,
developmental delay, ataxia, progressive spasticity, and dif-
fuse abnormality of the white matter on brain magnetic reso-
nance imaging (MRI). PMD is caused by mutations in PLP1,
encoding for myelin proteolipid protein, a major protein
component of central nervous system myelin (Madry et al.
2010). The clinically similar disease, Pelizaeus-Merzbacher-
like disease (PMLD; MIM #608804), shares several features
of PMD; however, patients with PMLD typically possess
better cognitive and motor function. In addition, PMLD
is usually inherited in an autosomal recessive manner in
both males and females (Biancheri et al. 2013) and exhibits
Electronic supplementary material The online version of this
article (https://doi.org/10.1007/s00439-019-02077-7) contains
supplementary material, which is available to authorized users.
* Isabelle Schrauwen
isabelle.schrauwen@gmail.com
* Sampathkumar Rangasamy
srangasamy@tgen.org
1
Center for Rare Childhood Disorders, Translational
Genomics Research Institute, Phoenix, AZ, USA
2
Neurogenomics Division, Translational Genomics Research
Institute, Phoenix, AZ, USA
3
Present Address: Department of Translational Genomics,
University of Southern California, Los Angeles, CA, USA
4
Present Address: Center for Statistical Genetics, Department
of Neurology, Gertrude H. Sergievsky Center, Columbia
University Medical Center, New York, NY, USA